rhinovirus
respons
episod
human
ill
infecti
agent
children
adult
one
ill
due
rhinoviru
everi
year
ill
per
personyear
rhinovirus
predomin
caus
common
cold
complex
subject
symptom
well
known
everyon
clinic
ill
character
sorescratchi
throat
nasal
obstruct
rhinorrhea
malais
cough
andor
sneez
may
present
young
children
may
fever
earli
ill
adult
usual
although
symptom
sign
may
persist
day
children
adult
ill
subsid
day
onset
rhinoviru
infect
commonli
precipit
exacerb
asthma
chronic
bronchiti
may
predispos
secondari
bacteri
infect
paranas
sinus
middl
ear
healthi
children
adult
articl
intend
review
aspect
viru
diseas
instead
three
area
may
interest
clinic
virologist
discuss
first
attribut
viru
epidemiolog
diseas
seem
clinic
relev
highlight
second
effici
method
detect
presenc
viru
human
respiratori
tract
analyz
third
mean
symptomat
ill
produc
rhinoviru
infect
respiratori
tract
discuss
rhinoviru
member
picornaviru
famili
viru
contain
singlestrand
rna
within
capsid
icosahedr
symmetri
compos
copi
four
polypeptid
viral
particl
nm
diamet
appear
nondescript
dot
electron
microscopi
infect
viru
destroy
acid
treatment
ph
differenti
enterovirus
surfac
rhinoviru
notabl
presenc
depress
canyon
base
site
attach
receptor
surfac
suscept
target
cell
major
rhinoviru
immunotyp
recogn
type
bind
intercellular
adhes
receptor
host
cell
receptor
remain
immunotyp
known
neutral
test
anim
hyperimmun
sera
use
identifi
differ
immunotyp
given
number
neutral
viru
infect
antibodi
occur
igg
bind
viral
surfac
access
host
cell
receptor
canyon
block
receptor
bind
site
base
canyon
inaccess
antibodi
highli
conserv
across
immunotyp
rhinoviru
infect
human
respiratori
epithelium
evid
cell
submucosa
respiratori
tract
infect
viru
detect
blood
optim
temperatur
rang
growth
viru
uitro
c
temperatur
rang
normal
nasal
mucosa
nose
nasopharynx
primari
site
viral
replic
human
whether
viru
replic
lung
bronchial
epithelium
rhinoviru
infect
definit
settl
due
difficulti
obtain
materi
lower
airway
uncontamin
nasal
secret
experiment
infect
rhinoviru
detect
frequent
nasopharynx
fig
one
studi
rhinoviru
inocul
onto
conjunctiv
surfac
suscept
volunt
deliv
nose
inferior
turbin
point
nasolacrim
duct
enter
four
site
nose
anterior
posterior
part
inferior
turbin
one
site
nasopharyng
wall
sampl
daili
small
cytolog
brush
brush
sampl
cultur
rhinoviru
viral
recoveri
rate
nasopharynx
consist
higher
combin
intranas
site
fig
viru
detect
earlier
nasopharynx
persist
rapid
declin
occur
day
inocul
author
suggest
viral
replic
occur
cell
viru
posit
site
recov
viru
may
present
mucu
overli
site
higher
viral
recoveri
rate
nasopharynx
may
simpli
reflect
fact
site
endpoint
mucociliari
clearanc
system
nasal
caviti
paranas
sinus
middl
ear
rhinoviru
cold
occur
year
round
howev
sharp
rise
rhinoviru
infect
occur
everi
septemb
rhinoviru
peak
initi
yearli
epidem
cold
temper
climat
result
success
wave
differ
virus
move
popul
cold
summertim
infrequ
proport
summer
earli
fall
cold
due
rhinoviru
high
ill
appear
day
rhinoviru
inocul
onto
nasal
mucosa
oral
inocul
viru
ineffect
mean
initi
infect
home
environ
conduc
transmiss
rhinoviru
infect
rhinoviru
may
transfer
ill
person
nasal
mucosa
suscept
person
way
one
transmiss
rout
smallparticl
aerosol
largeparticl
aerosol
direct
contact
viruscontamin
hand
conjunctiv
nasal
mucosa
handhelfinocul
rout
rout
transmiss
rhinoviru
spread
natur
condit
establish
frequent
hand
wash
remov
viru
may
reduc
likelihood
infect
acquir
selfinocul
immun
reinfect
immunotyp
rhinoviru
correl
necessarili
mediat
neutral
antibodi
serum
serum
antibodi
appear
persist
year
immun
one
immunotyp
provid
protect
type
consequ
rhinoviru
vaccin
practic
prospect
rhinovirus
long
known
major
etiolog
agent
common
cold
studi
sever
investig
use
sampl
nasal
secret
inocul
prior
freez
either
hela
cell
human
embryon
lung
fibroblast
secret
shown
rhinoviru
posit
sampl
nasopharyng
secret
swab
nasal
wash
use
cell
optim
sensit
rhinoviru
incub
cell
cultur
condit
motion
import
requisit
achiev
result
recent
refin
cultur
diagnosi
use
polymeras
chain
reaction
pcr
technolog
common
cold
shown
due
rhinoviru
section
inform
effici
mean
detect
rhinoviru
upper
respiratori
tract
may
help
clinic
virologist
review
infect
rhinoviru
present
frequent
nasopharynx
secret
nasopharynx
obtain
one
three
method
intranas
swab
insert
far
enough
nose
reach
posterior
nasopharyng
wall
aspir
nasopharyng
mucu
thin
tube
insert
nose
nasal
wash
ml
physiolog
salt
solut
subject
toler
aspir
mucu
present
nasopharynx
method
expect
effici
rel
effici
nasal
swab
nasal
wash
compar
two
studi
cate
cowork
compar
detect
rate
rhinoviru
nasal
wash
nasal
swab
pharyng
swab
experiment
infect
volunt
day
inocul
viru
detect
nasal
wash
nasal
swab
pharyng
swab
viru
detect
sampl
result
nasal
pharyng
swab
combin
arruda
et
al
compar
isol
rate
rhinoviru
nasal
wash
vigor
deep
nasal
swab
sampl
nostril
combin
pharyng
swab
subject
natur
acquir
common
cold
fall
viru
grown
cell
one
supplier
nasal
wash
compar
nose
throat
swab
sampl
find
two
studi
suggest
nasal
wash
effici
nasal
swab
detect
rhinoviru
transport
nasopharyng
secret
dispers
medium
contain
protein
immedi
inocul
cell
cultur
conveni
sampl
store
frozen
one
freezethaw
cycl
prior
inocul
appear
reduc
recoveri
rate
rhinoviru
arruda
et
al
emphas
effici
detect
rhinoviru
cell
cultur
increas
use
one
sensit
cell
type
compar
recoveri
rate
rhinoviru
nasal
wash
subject
natur
cold
sever
cell
type
strain
human
embryon
lung
fibroblast
rhinovirussuscept
clone
hela
cell
sensit
type
use
howev
neither
cell
type
detect
rhinoviru
isol
subject
type
miss
posit
sampl
author
conclud
sampl
inocul
cell
suscept
hela
cell
order
maximum
sensit
cultur
detect
rhinoviru
strategi
inocul
sampl
fibroblast
hela
cell
rather
singl
type
also
use
makela
et
al
summari
effici
method
diagnosi
rhinoviru
infect
cultur
would
includ
sampl
nasopharyng
secret
nasal
wash
nasopharyng
aspir
store
sampl
dispers
proteincontain
medium
inocul
sampl
fibroblast
suscept
hela
cell
rna
picornaviru
genom
contain
kilobas
singl
open
read
frame
preced
noncod
region
contain
short
highli
conserv
sequenc
nucleotid
sequenc
number
human
picornavirus
delin
synthet
oligonucleotid
probe
use
hybrid
assay
detect
picornavirus
howev
use
direct
hybrid
detect
viru
respiratori
sampl
limit
copi
viral
genom
requir
posit
result
begin
late
conserv
sequenc
employ
prime
revers
transcript
rt
segment
viral
rna
produc
cdna
amplif
pcr
rtpcr
refin
rtpcr
result
format
allow
detect
one
viral
genom
sampl
upper
respiratori
tract
detect
rhinoviru
respiratori
secret
rtpcr
sever
thing
note
nasal
mucu
may
contain
rnase
inhibitor
transcriptasepolymeras
enzymat
activ
order
assay
sensit
enough
detect
one
genom
either
nest
pcr
detect
amplim
gel
ethidium
bromid
stain
standard
pcr
detect
amplim
hybrid
label
oligonucleotid
probe
must
use
final
identif
picornaviru
genom
materi
respiratori
sampl
may
indic
infect
either
rhinoviru
enteroviru
two
virus
differenti
use
primer
amplifi
region
picornaviru
genom
number
nucleotid
base
rhinoviru
rna
differ
enteroviru
rna
amplim
distinguish
gel
electrophoresi
altern
product
pcr
amplif
conserv
sequenc
may
detect
oligonucleotid
probe
specif
either
rhinoviru
enteroviru
genom
four
epidemiolog
studi
publish
sinc
util
rtpcr
cell
cultur
detect
rhinovirus
respiratori
tract
sampl
adult
children
natur
acquir
cold
studi
illustr
variat
rtpcr
format
develop
detect
rhinoviru
clinic
sampl
addit
allow
comparison
effici
rtpcr
cell
cultur
rhinoviru
diagnosi
highlight
featur
rtpcr
protocol
shown
abbrevi
telegraph
form
tabl
full
descript
protocol
provid
referenc
public
four
studi
sampl
respiratori
secret
test
rtpcr
inocul
cell
cultur
store
frozen
without
addit
rna
extract
thaw
sampl
three
four
proteinas
k
treatment
follow
phenol
extract
ethanol
precipit
fourth
sampl
rna
recov
use
commerci
avail
matrix
affin
chromatographi
column
primer
use
rt
pcr
four
studi
noncod
region
picornaviru
genom
except
one
primer
code
region
method
use
makela
et
al
three
studi
pcr
product
detect
use
label
oligonucleotid
probe
fourth
amplim
nest
pcr
detect
ethidium
bromid
stain
electrophoret
separ
agaros
gel
differenti
rhinoviru
enteroviru
base
size
amplim
hybrid
rhinovirusspecif
probe
differenti
done
studi
sampl
collect
fall
four
studi
respiratori
tract
sampl
peopl
cold
test
rhinoviru
cell
cultur
inocul
rtpcr
tabl
sampl
obtain
year
round
three
studi
fourth
obtain
fall
time
highest
rhinoviru
preval
appropri
sampl
nasopharyng
mucu
obtain
three
four
studi
anterior
nasal
swab
cultur
fourth
studi
would
expect
provid
maximum
sensit
nasopharyng
secret
sampl
accord
expect
detect
rate
rhinoviru
studi
rhinovirus
detect
cold
yearround
surveil
rtpcr
result
combin
cell
cultur
detect
ill
fall
associ
rhinoviru
rel
sensit
detect
rhinoviru
cell
cultur
inocul
could
compar
rtpcr
three
studi
nasopharyng
secret
obtain
one
sensit
cell
line
inocul
one
studi
rhinoviru
posit
detect
cell
cultur
wherea
rtpcr
detect
contrast
two
studi
two
sensit
cell
line
inocul
rhinoviru
grown
cell
cultur
posit
sampl
rtpcr
posit
although
rtpcr
sensit
properli
done
cell
cultur
inocul
use
two
cell
system
detect
three
everi
four
posit
sampl
appropri
precaut
prevent
falseposit
result
employ
pcr
protocol
studi
consist
result
cell
cultur
detect
viru
least
three
quarter
indic
rtpcr
result
true
posit
reason
conclud
nasopharyng
mucu
must
sampl
reliabl
detect
rhinoviru
rtpcr
sensit
way
detect
viru
cell
cultur
two
sensit
cell
line
sensit
fulli
cold
year
children
adult
due
rhinoviru
three
report
publish
inform
symptom
pathogenesi
rhinoviru
infect
review
referenc
articl
select
featur
current
knowledg
symptom
pathogenesi
emphas
background
specul
viral
infect
host
respons
viral
infect
symptom
perceiv
host
may
fit
togeth
five
featur
rhinoviru
infect
human
nose
deserv
emphasi
discern
destruct
nasal
epithelium
viru
rhinoviru
infect
either
vivo
vitro
featur
illustr
studi
nasal
epithelium
cultur
infect
four
differ
respiratori
virus
rhinoviru
coronaviru
produc
appar
cytopath
effect
epitheli
monolay
wherea
adenoviru
influenza
viru
profound
effect
fig
pictur
obvious
differ
produc
rhinoviru
infect
suscept
fibroblast
cultur
fig
volunt
infect
ill
elev
level
inflammatori
marker
nasal
wash
volunt
model
symptom
sever
viral
titer
concentr
serum
albumin
polymorphonuclear
neutrophil
pmn
kinin
peak
hour
inocul
rise
fall
parallel
symptomat
ill
subsid
adult
day
spite
fact
viru
disappear
nasopharynx
day
inocul
fig
persist
viru
absenc
symptom
seen
studi
fig
taken
featur
mind
one
specul
mechan
symptom
produc
rhinoviru
infect
nasal
mucosa
follow
inocul
viru
nose
singl
epitheli
cell
infect
elabor
cytokin
chemokin
distress
signal
cytokin
releas
result
local
vascular
leak
extravas
albumin
serum
protein
influx
pmn
mucosa
effect
appear
kinin
nasal
secret
side
effect
vascular
leakag
kininogen
enough
epitheli
cell
infect
elabor
cytokin
inflammatori
respons
produc
symptomat
ill
time
local
inflammatori
respons
effect
limit
viral
replic
perhap
wash
extrud
infect
cell
away
epitheli
surfac
viru
spread
neighbor
cell
result
declin
viral
titer
peak
hour
postinocul
fewer
cell
infect
extent
inflammatori
respons
symptom
diminish
final
second
third
week
inocul
suffici
neutral
antibodi
becom
avail
shut
viral
replic
infect
end
antibodi
may
secretori
iga
serum
igg
leak
mucosa
brief
symptom
rhinoviru
infect
nose
appear
caus
host
respons
virusp
se
introduc
notion
viru
need
kill
amelior
ill
host
respons
alter
howev
note
use
oral
prednison
broad
potent
antiinflammatori
agent
infect
volunt
result
increas
titer
rhinoviru
nasal
wash
find
consist
specul
local
inflammatori
respons
rhinoviru
infect
epitheli
cell
instrument
limit
viral
replic
nasal
mucosa
although
theoret
need
kill
viru
order
reduc
symptom
effect
antivir
may
requir
conjunct
antiinflammatori
treatment
order
alter
ill
view
demonstr
enhanc
viral
replic
steroid
rhinovirus
caus
infect
human
microorgan
acidsensit
picornavirus
infect
epitheli
cell
follow
inocul
onto
nasal
mucosa
detect
reliabl
nasopharyng
secret
rhinoviru
cold
occur
year
round
peak
ill
fall
typespecif
serum
antibodi
correl
protect
infect
fact
least
differ
immunotyp
make
develop
effect
vaccin
unlik
nasopharyng
secret
must
sampl
detect
rhinoviru
cultur
rtpcr
effici
isol
viru
requir
inocul
two
differ
type
sensit
cell
cultur
ie
fibroblast
hela
cell
rt
conserv
sequenc
noncod
region
viral
rna
produc
cdna
pcr
amplif
coupl
detect
amplim
either
gel
electrophoresi
nest
pcr
hybrid
label
oligonucleotid
probe
detect
one
viral
genom
sampl
two
studi
rtpcr
cell
cultur
use
virtual
posit
identifi
rtpcr
cultur
two
cell
line
identifi
posit
yearround
surveil
cold
adult
children
rhinoviru
posit
symptom
occur
rhinoviru
cold
caus
host
respons
viru
viru
elabor
cytokin
infect
epitheli
cell
central
symptom
pathogenesi
